Alprostadil in Maculopathy Study (AIMS)
Condition(s):Macular DegenerationLast Updated:October 27, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Macular DegenerationLast Updated:October 27, 2014Terminated
Condition(s):Nonexudative Age-related Macular DegenerationLast Updated:April 21, 2014Completed
Condition(s):Retinal Angiomatous ProliferationLast Updated:August 22, 2022Recruiting
Condition(s):Age-related Macular DegenerationLast Updated:January 30, 2024Completed
Condition(s):Age-Related Macular Degeneration; Geographic Atrophy; Diabetic Retinopathy; Macular Edema; Retinal Vein Occlusion; Central Serous Retinopathy; Pattern Dystrophy of Macula; Epiretinal Membrane; Macular HoleLast Updated:May 10, 2017Completed
Condition(s):Age-related Macular Degeneration; Choroidal Neovascular Age-related Macular DegenerationLast Updated:January 20, 2014Completed
Condition(s):Age-Related Macular DegenerationLast Updated:February 9, 2024Recruiting
Condition(s):Retinal Disease; Macular Degeneration; Hereditary Retinal Dystrophy; Optic Nerve Disease; GlaucomaLast Updated:October 23, 2019Unknown status
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:March 12, 2024Completed
Condition(s):Retinal Disease; Age-Related Macular Degeneration; Retinitis Pigmentosa; Stargardt Disease; Optic Neuropathy; Nonarteritic Ischemic Optic Neuropathy; Optic Atrophy; Optic Nerve Disease; Glaucoma; Leber Hereditary Optic Neuropathy; Blindness; Vision Loss Night; Vision Loss Partial; Vision, Low; Retinopathy; Maculopathy; Macular Degeneration; Retina AtrophyLast Updated:June 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.